Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2012

Global medical equipment market: Deal value declines in 2012 to $119 billion


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-03-05 07:29:03 - Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2012 - a new market research report on companiesandmarkets.com

The global medical equipment market reported a decline in the number of deals and deal values in 2012, due to continued economic uncertainty. The industry recorded 2,868 deals worth $119.3 billion in 2012, as compared to 2,917 deals worth $143.2 billion in 2011. The venture capital (VC) market topped the deal activity in the medical equipment industry, accounting for 34% of the total deals in 2012. Venture capital provided considerable impetus to the medical equipment industry in 2012. In-vitro diagnostics market continues to be on the top in attracting investors´ attention, as the market showed rapid growth in spite of the economic recession. The market recorded 742 deals in 2012. North America remains the favored destination for investors. The region

 

 

recorded 2,209 deals in 2012.

The Number Of M&As And Their Values Declined 5% And 28%, Respectively, In 2012

Mergers and acquisitions (M&As), including asset transactions, recorded a decrease in the number of deals and deal values in 2012, due to valuation gaps between acquirers and sellers. The medical equipment industry reported 610 deals worth $50 billion in 2012, as compared to 647 deals worth $70.7 billion in 2011. Healthcare IT market managed to remain attractive to buyers in 2012. The market topped the deal activity with 151 deals worth $10.6 billion in 2012. Out of 610 deals announced in 2012, 478 were acquisitions worth $46.8 billion, 122 were asset transactions worth $3.5 billion, and 10 were mergers with undisclosed deal value.

Some of the high value acquisitions in 2012 include Linde AG, a Germany-based industrial gases and engineering company, completing the acquisition of Lincare Holdings, Inc., a provider of oxygen and other respiratory therapy services, for a purchase consideration of $41.5 per share or $4,600m in cash; SXC Health Solutions Corp. (SXCI), a provider of pharmacy benefit management services, through its wholly-owned subsidiary, completing the acquisition of Catalyst Health Solutions, Inc. (CHSI), a pharmacy benefit management company, for a purchase consideration of $4,400m in a cash and stock transaction and Baxter International, Inc., a global healthcare company, announcing the acquisition of Gambro AB, a medical technology company, from EQT Partners AB, a private equity firm and Investor AB, an investment company, for a total purchase consideration of SEK26.5 billion (approximately $4 billion).

The number of M&As and also their values are expected to increase in 2013 compared to 2012 due to increasing growth prospects in the US and emerging countries such as China.

IPO Market Decreased In 2012

Equity offerings recorded a decrease in the number of deals and an increase in deal values in 2012. The industry recorded 289 deals worth $8 billion in 2012, as compared to 304 deals worth $6.4 billion in 2011.

Deals in the IPO market decreased considerably in 2012. The market recorded 19 deals worth $779.8m in 2012, as compared to 29 deals worth $1.6 billion in 2011. Majority of the companies in the in vitro diagnostics business were keen to come out with their IPOs in 2012. Five in vitro diagnostics companies have announced their IPOs in 2012. Besides, the industry recorded 96 secondary offerings worth $4.7 billion and 174 deals worth $2.5 billion in 2012.

In 2012, the industry recorded 107 deals worth $46.8 billion in 2012, as compared to 110 deals worth $39.7 billion in 2011. Of the 107 debt offerings reported in 2012, 36 were public debt offerings worth $18.7 billion and 71 private debt placement deals worth $28.1 billion.

Venture Capital Investments Declined In 2012

The venture capital (VC) market recorded a decline in the value of deals in 2012. The decline in venture capital investments resulted from drop in venture fundraising and less capital available for new investments. The medical equipment industry recorded deals worth $6 billion in 2012, as compared to $7 billion in 2011. However, the number of deals increased marginally to 966 in 2012 from 965 in 2011.

In 2012, growth capital/expansion stage companies managed to attract much investment. The companies in growth capital/expansion stage received approximately $2 billion investments in 2012.

Domain Associates, a venture capital firm with $2.4 billion assets under management, topped the list of venture financing firms by participating in 14 deals worth $345.8m in last one year.

Private equity (PE) market reported an increase in the number of deals and a decrease in deal values with 88 deals worth $7.6 billion in 2012, as compared to 71 deals worth $18.8 billion in 2011.

Number of PE/VC investments and also their value are expected to increase in 2013 compared to 2012 as growth becomes challenging for big established companies. Growth and expansion stage companies developing innovative technologies and solutions catering to the growing patient population will inevitably attract PE/VC firms attention and investments.

North America Reported A Decline In Deal Activity In 2012

North America reported an increase in the number of deals and a decrease in deal values in 2012. The region recorded 2,209 deals worth $83.3 billion in 2012, as compared to 2,196 deals worth $88 billion in 2011, with uncertainty in the global economy discouraging companies in the region from making investments.

North America is expected to continue to witness in increase in number of M&As. Also the value of M&As is expected to reverse the trend and will witness increase in deal values due to improving growth prospects in the US and organic growth becoming a challenge to big companies.

Europe recorded a decrease in the number of deals and deal values in 2012. The region reported 587 deals worth $24.9 billion in 2012, as compared to 666 deals worth $50.1 billion in 2011, reflecting a decrease of 12% and 50%, respectively.

The Asia-Pacific region recorded a decrease in the number of deals and an increase in deal values in 2012. The region reported 353 deals worth $11.6 billion in 2012, as compared to 381 deals worth $4.9 billion in 2011.

Report Overview

This report is an essential source of data and trend analysis on mergers and acquisitions (M&A) and financing in the medical equipment market. The report provides detailed information on M&A, equity/debt offerings, private equity (PE), venture financing and partnership transactions registered in the medical equipment industry in 2012. The report includes detailed comparative data on the number of deals and their value in the past four quarters, categorized into deal types, segments, and geographies. Additionally, the report provides information on the top PE, venture capital (VC), and advisory firms in the medical equipment industry.

Scope

- Analyze market trends for the medical equipment/medical devices market in the global arena
- Review of deal trends in anesthesia and respiratory devices, cardiovascular devices, dental devices, diabetes care devices, diagnostic imaging, drug delivery devices, endoscopy devices, ENT devices, healthcare IT, hospital supplies, in vitro diagnostics, nephrology and urology devices, neurology devices, opthalmic devices, patient monitoring, surgical equipment, and wound care management segments
- Analysis of M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships in the medical equipment market
- Summary of medical equipment deals globally in the last five years
- Information on the top deals that took place in the medical equipment market
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa
- League Tables of financial advisors in M&A and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs
- Review the financial metrics, such as operating profit ratio, P/E ratio, and EV/EBITDA on mergers and acquisitions

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner
- Find out the major deal performing segments for investments in your industry
- Evaluate type of companies divesting / acquiring and ways to raise capital in the market
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the medical equipment market
- Identify major private equity/venture capital firms that are providing finance in the medical equipment market
- Identify growth segments and opportunities in each region within the industry
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry
- Identify top deals makers in the medical equipment market

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com